An assessment of nucleic acid amplification testing for active mycobacterial infection

Data sources used in the financial analysis

The sources for data used in the financial analysis are presented in Table .

Table Data sources used in the financial analysis

Data	Source
Population eligible for NAAT	MBS data requested from the Department of Health relating to the number of patients who accessed at least one service from items 69324, 69325, 69327, 69328, 69330 or 69331 for the calendar years 200913. These data are projected to estimate the number of patients eligible for NAAT during 201519.
Proportion of patients eligible for NAAT suspected of TB	Applicant estimate of mycobacterial infections tested suspected of TB (50%). The inverse is the estimate of mycobacterial infections tested that are suspected of NTM.
Cost of NAAT for TB	As per ‘Economic evaluation’ ($130)
Cost of NAAT for NTM	Victorian Mycobacterium Reference Laboratory price per NAAT for suspected M. ulcerans infections ($50) or generic region Mycobacterium PCR ($120)
Proportion of patients bulk-billed	MBS data requested from the Department of Health regarding the proportion of patients who accessed at least one service from items 69324, 69325, 69327, 69328, 69330 or 69331 for the calendar years 200913 who were bulk-billed.

NAAT = nucleic acid amplification test; NTM = non-tuberculous mycobacteria; TB = tuberculosis